PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

In a hearing at the Inter-American Court of Human Rights, human rights organisations denounced the continued repression and ...

The Medical University of South Carolina will be the first clinical trial site in the country to test a new kind of cochlear ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

Providers and lawmakers fear that payments for some federally funded health programs aren’t being dispersed amid confusing ...

KFSN-TV Fresno (hereinafter referred to as "Sponsor"), 1777 G Street, Fresno, CA 93706.

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

Q3 2025 Earnings Conference Call February 6, 2025 5:30 PM ETCompany ParticipantsLisa Curran - Vice President of ...

WABC-TV, American Broadcasting Companies, Inc. (hereinafter referred to as "Sponsor"), 7 Lincoln Square, New York, NY 10023.

Apprehension has continued to trail the recent Executive Order by President of the United States of America, Donald Trump to halt foreign aid to African countries as thousands of employees at the US ...

Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...